/PRNewswire/ Daewoong Pharmaceutical s Bersiporocin (DWN12088) has been recognized as a significant advancement in treating idiopathic pulmonary fibrosis.
On Monday, 2391 stocks advanced, 1467 declined and 177 remained unchanged, with an advance decline ratio of 1.63 on the Bombay Stock Exchange (BSE), indicating positive closing of stocks in broader markets.
/PRNewswire/ Daewoong Pharmaceutical is pleased to announce that its Osong factory in Korea achieved Good Manufacturing Practice (GMP) certification from.
/PRNewswire/ Daewoong Pharmaceutical (KRX: 069620.KS) is pleased to announce its financial results for the third quarter of 2023. Demonstrating a consistent.